AJM online
Clinical communication to the Editor
Cholangiocarcinoma Presenting as Metastases to the Cervical Spine

https://doi.org/10.1016/j.amjmed.2010.12.011Get rights and content

Section snippets

Discussion

In this case report, we present a case of metastatic cholangiocarcinoma to the cervical spine. To our knowledge, this is the first published report of cervical spinal metastasis as the initial presentation of cholangiocarcinoma.

Cholangiocarcinoma most commonly advances locally and regionally by invading lymph nodes, but distant metastasis to cervical lymph nodes in the head and neck have been described.3, 4 In addition, there is a single published case report describing cholangiocarcinoma

References (6)

  • P.H. Yiannakis et al.

    Metastatic cholangiocarcinoma with an occult primary

    Clin Oncol (R Coll Radiol)

    (1995)
  • T.N. Byrne

    Spinal cord compression from epidural metastases

    N Engl J Med

    (1992)
  • J.P. Constans et al.

    Spinal metastases with neurological manifestationsReview of 600 cases

    J Neurosurg

    (1983)
There are more references available in the full text version of this article.

Cited by (11)

  • Cholangiocarcinoma with spinal metastasis: Single center survival analysis

    2017, Journal of Clinical Neuroscience
    Citation Excerpt :

    Cholangiocarcinoma (CCA) is an epithelial cell malignancy arising from various locations within the biliary tree, presenting the marker for cholangiocyte differentiation [1]. CCA tends to progress locally and regionally by spreading through the lymphatic system with metastases through the venous and lymphatic systems [2–5]. The incidence of CCA varies worldwide and the highest incidence is in Khon Kaen province, Thailand, where the incidence is 44.3 and 17.6 per 100,000 males and females, respectively [6].

  • Non-hepatocellular carcinoma spinal metastases

    2016, Journal of Clinical Neuroscience
    Citation Excerpt :

    A recent literature review of 40 adult patients with hepatoblastoma revealed an overall median survival time of 4 months, and a 1 year survival rate of 29.6% [12]. Each of these tumors has a poor prognosis with few reports in the literature of metastases from these neoplasms to any location, and only a minority of these reports in the known literature includes metastases to the skeletal system [7,10,13,14]. Although the existing literature on clinical outcomes following a diagnosis of non-hepatocellular carcinoma metastasis to the spine is limited, it is expected that an increased number of patients will present with a diagnosis of metastatic disease or the sequelae of these malignancies in the future.

  • Distal fibula metastasis of cholangiocarcinoma

    2013, Journal of Foot and Ankle Surgery
  • Aberrant pattern of the cytokeratin 7/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations

    2012, Pathology Research and Practice
    Citation Excerpt :

    Bayrak et al. [1] recently suggested that 17.3% of colorectal adenocarcinomas (CRC) expressed cytokeratin 7 (CK7) and 18.9% of cases did not express cytokeratin 20 (CK20), although most authors admit that CK20 is of great importance in the differentiation of colonic metastases from other metastatic tumors like lung, bladder, breast carcinomas and cholangiocarcinomas [4,5,8].

View all citing articles on Scopus

Funding: None.

Conflict of Interest: None of the authors have any conflicts of interest associated with the work presented in this manuscript.

Authorship: All listed authors had access to the data used in the paper and contributed to the writing of the manuscript.

View full text